ARTICLE | Company News
3-Dimensional, GlaxoSmithKline deal
January 14, 2002 8:00 AM UTC
DDDP exclusively licensed from GSK worldwide development, marketing and distribution rights to preclinical compound GW 395058 to prevent and treat thrombocytopenia. The product is a pegylated syntheti...